Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Zimmer has received eleven (11) complaints over a six-year timeframe that the sterile bag containing the implant contains a black residue now identified as a combination of the titanium plasma spray used to create the porous surface of the implant and polyethylebe bag containing the implant within the sterile package. all complaints were related to product that has been distributed through the loaner pool. zimmer is therefore initiating a recall of m/l taper stems and m/l taper with kinectiv stems that are in the loaner pool and is suspending provision of these devices to the loaner pool.
“The safety of patients has always been, and continues to be, Zimmer Biomet’s top priority and it is our honor to be a leader in this industry for the past 90 years,” Zimmer Biomet told ICIJ in a statement. “We adhere to strict regulatory standards, and work closely with the FDA and all applicable regulatory agencies in each of our regions as part of our commitment to operating a first-rate quality management system across our global manufacturing network. The company added that it is focused on staying at the forefront of innovation and doing right by the millions of patients who rely on the company’s products.